This inventor holds 1 USPTO granted patent. Top assignee: Behringwerke Aktiengesellschaft. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Wolfgang Dippold: Innovator in Monoclonal Antibodies
Introduction
Wolfgang Dippold is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for cancer detection and treatment, showcasing the importance of innovation in medical science.
Latest Patents
Dippold holds a patent for a monoclonal anti-ganglioside antibody and its preparation. This invention relates to monoclonal antibodies of high avidity that specifically react with the gangliosides GD3 and GQ1b. The patent highlights their use in detecting melanomas and other tumors or tissues that express GD3 and GQ1b. This advancement represents a crucial step in improving diagnostic methods for cancer.
Career Highlights
Throughout his career, Wolfgang Dippold has been associated with Behringwerke Aktiengesellschaft, a prominent company in the biopharmaceutical sector. His work at Behringwerke has allowed him to focus on innovative solutions in antibody development, contributing to the company's reputation for excellence in medical research.
Collaborations
Dippold has collaborated with esteemed colleagues such as Klaus Bosslet and Gerhard Seemann. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the quality of their research and innovations.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile